The utility of retinoic acid receptor (RAR) alpha agonists for the treatment of neurodegenerative diseases

Project: Research

Project Details

StatusFinished
Effective start/end date1/01/200631/12/2006

Funding

  • Heptagon Proof of Concept Fund: £92,823.00